angiotensin ii has been researched along with Injury, Myocardial Reperfusion in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.30) | 18.7374 |
1990's | 28 (32.18) | 18.2507 |
2000's | 28 (32.18) | 29.6817 |
2010's | 26 (29.89) | 24.3611 |
2020's | 3 (3.45) | 2.80 |
Authors | Studies |
---|---|
Boylston, J; Casin, KM; Fillmore, N; Kohr, MJ; Liu, C; Ma, H; Murphy, E; Noguchi, A; Sinha, P; Sun, J; Wang, N; Zhou, G | 1 |
Barbato, E; Bellis, A; Di Gioia, G; Mauro, C; Morisco, C; Sorriento, D; Trimarco, B | 1 |
Mao, Y; Wang, M; Xie, H | 1 |
Che, Y; Chen, R; Liu, F; Su, Z; Tian, Y; Xia, L | 1 |
Escobales, N; Javadov, S; Nuñez, RE | 3 |
Barreto-Chaves, ML; da Silva, IB; Gomes, DA; Tavares, FM | 1 |
Castro, M; Escobales, N; Javadov, S; Nuñez, RE | 1 |
Dai, Y; Ding, Z; Khaidakov, M; Mehta, JL; Mercanti, F; Romeo, F; Sawamura, T; Wang, X | 1 |
Bajulaiye, A; Libonati, JR; Mann, S; Muthukumaran, G; Sabri, A; Sturgeon, K | 1 |
Chen, P; Li, X; Luo, J; Patterson, AJ; Xue, Q; Zhang, G | 1 |
Barreto-Chaves, ML; da Silva, IB; Lino, CA; Monteiro, Pde S; Shibata, CE | 1 |
Li, C; Wang, G; Wu, J; Yuan, W; Zhang, Q | 2 |
Cha, SA; Kim, SH; Lee, SH; Park, BM | 1 |
Jiang, B; Lee, HC; Lu, T; Wang, XL | 1 |
Al-Jarallah, A; Babiker, F; Joseph, S | 1 |
Dursun, N; Guven, C; Kaya, ST; Taskin, E; Tuncer, KA | 1 |
Kim, J; Kook, H; Park, WJ | 1 |
Forster, ME; Pemberton, CJ; Prosser, HC; Richards, AM | 1 |
Al-Maghrebi, M; Benter, IF; Diz, DI | 1 |
Cummins, PM | 1 |
Curtis, MJ; Stables, CL | 1 |
Cao, CM; Cheng, H; Peng, W; Xiao, RP; Zhang, Y; Zheng, M; Zhu, W | 1 |
Ceyhan, BM; Cüre, MC; Gülmen, S; Kiriş, I; Lortlar, N; Okutan, H; Oyar, EÖ; Sütcü, R | 1 |
Bengel, FM; Bravo, PE; Dannals, RF; Fukushima, K; Higuchi, T; Javadi, MS; Lautamäki, R; Mathews, WB; Szabo, Z; Xia, J | 1 |
Al-Saad, S; Aljabri, MB; Andreasen, TV; Höper, AC; Lindal, S; Lund, T; Ytrehus, K | 1 |
Al-Saleh, FM; Benter, IF; Chappell, MC; Diz, DI; Raghupathy, R; Yousif, MH | 1 |
Han, B; Qu, S; Shi, Y; Sui, D; Yu, X | 1 |
Fukui, A; Hara, M; Murozono, Y; Nagano-Torigoe, Y; Nakagawa, M; Ooie, T; Saikawa, T; Shinohara, T; Takahashi, N; Taniguchi, Y; Teshima, Y; Thuc, LC; Wakisaka, O; Yoshimatsu, H; Yufu, K | 1 |
Chan, NY; Hashikawa-Hobara, N; Levi, R | 1 |
Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Kocsis, GF; Pálóczi, J; Pipicz, M; Sárközy, M; Varga, ZV | 1 |
Ecarnot-Laubriet, A; Oudot, A; Rochette, L; Vergely, C | 1 |
Allen, DG; Xiao, XH | 1 |
Browne, AE; Chatterjee, K; Grossman, W; Karliner, JS; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ | 1 |
Chen, CX; Shen, YH | 1 |
du Toit, EF; Lochner, A; Nabben, M | 1 |
Abe, Y; Fan, YY; Kimura, S; Maeta, H; Nishiyama, A; Rahman, M; Shokoji, T; Suzuki, T; Yao, L; Zhang, GX | 1 |
Colson, P; Foëx, P; Guillon, G; Ryckwaert, F | 1 |
Feng, B; He, ZY; Liu, W; Xu, J; Yang, HB | 1 |
Maeda, T; Makino, N; Oyama, J; Satoh, S; Sugano, M | 1 |
Das, DK; Das, S; Engelman, RM; Maulik, N | 1 |
Das, DK; Das, S; Maulik, N; Otani, H | 1 |
Dawn, B | 1 |
Bell, RM; Clark, JE; Hearse, DJ; Shattock, MJ | 1 |
Berti, F; Berti, M; Bianchi, M; Bonomo, S; De Gennaro Colonna, V; Ferrario, P; Guazzi, M; Manfredi, B; Muller, EE; Rossoni, G | 1 |
Hartman, JC | 1 |
Xu, S; Zhang, Y | 1 |
Akioka, K; Kim, S; Omura, T; Takeuchi, K; Tani, T; Teragaki, M; Toda, I; Yamagishi, H; Yanagi, S; Yoshiyama, M | 1 |
Akioka, K; Kim, S; Omura, T; Takagi, M; Takeuchi, K; Tani, T; Teragaki, M; Toda, I; Yamagishi, H; Yoshiyama, M | 1 |
Liu, FM; Xu, SC | 1 |
Berdeaux, A; Ghaleh, B; Giudicelli, JF; Richard, V | 1 |
Brunner, F | 1 |
Hirayama, Y; Ibukiyama, C; Iga, K; Ishii, T; Kiyomi, S; Nagai, Y; Ogawa, T; Takata, Y | 1 |
Brunner, F; Kukovetz, WR | 1 |
Berti, F; Chiesara, E; Michael, M; Oriani, G; Radice, S; Rossoni, G | 1 |
Ding, YA; Lee, YM; Peng, YY; Yen, MH | 1 |
Bernareggi, M; Berti, F; De Gennaro Colonna, V; Müller, EE; Rossoni, G | 1 |
Browne, AE; Chatterjee, K; Chou, TM; Deedwania, PC; Gao, L; Glantz, SA; Hutchison, SJ; Parmley, WW; Sievers, RE; Sudhir, K; Sun, YP; Zhu, BQ | 1 |
Riva, E; Traquandi, C | 1 |
Bernareggi, M; Berti, F; De Gennaro Colonna, V; Müller, EE; Polvani, GL; Rossoni, G | 1 |
Kimura, B; Mehta, JL; Mehta, P; Phillips, MI; Shen, LP; Yang, BC; Zhang, YC | 1 |
Hayakawa, H; Jia, D; Kishida, H; Kusama, Y; Yasutake, M | 1 |
Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
Aldini, G; Berti, F; Bombardelli, E; Carini, M; Facino, RM; Morazzoni, P; Rossoni, G | 1 |
Sharma, A; Singh, M | 3 |
Allegrini, PR; Buser, PT; Hornstein, PS; Zaugg, CE; Zhu, P | 1 |
Croker, BP; Li, D; Mehta, JL; Mehta, P; Tomson, K; Yang, B | 1 |
Bernareggi, M; Berti, F; De Gennaro Colonna, V; Deghenghi, R; Locatelli, V; Müller, EE; Rossoni, G; Schweiger, F; Torsello, A | 1 |
Sjöquist, PO; Wang, QD | 1 |
Aldini, G; Berti, F; Carini, M; Maffei Facino, R; Rossoni, G | 1 |
Marchini, F; Morazzoni, G; Papp, JG; Parratt, JR; Rastegar, MA; Vegh, A | 1 |
Browne, AE; Chatterjee, K; Chou, TM; Lee, RJ; Parmley, WW; Pulukurthy, S; Sievers, RE; Sudhir, K; Sun, Y; Zhu, B | 1 |
Bernareggi, M; Berti, F; Berti, M; Colonna, VD; Del Soldato, P; Rossoni, G | 1 |
Barthel, H; Gonzàlez, M; Obal, D; Preckel, B; Schlack, W; Thämer, V | 1 |
Chernichovski, T; Frolkis, I; Gurevitch, J; Iaina, A; Kramer, A; Matsa, M; Mohr, R; Paz, Y; Pevni, D; Shapira, I; Wollman, Y; Yuhas, Y | 1 |
Guo, X; Luo, A; Wang, M; Xu, S; Zhao, X | 1 |
Chen, H; Kimura, B; Li, D; Mehta, JL; Mehta, P; Mohuczy, D; Phillips, MI | 1 |
Almeida, AP; Ferreira, AJ; Santos, RA | 1 |
Browne, AE; Chatterjee, K; Lee, RJ; Parmley, WW; Sievers, RE; Sun, Y; Zhu, B | 1 |
Curtis, MJ | 1 |
Becker, RC | 1 |
Linz, W; Schölkens, BA | 1 |
Albus, U; Breipohl, G; Knolle, J; Linz, W; Petry, P; Schölkens, BA | 1 |
4 review(s) available for angiotensin ii and Injury, Myocardial Reperfusion
Article | Year |
---|---|
The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.
Topics: Adrenomedullin; Aminobutyrates; Angiotensin II; Animals; Apelin; Atrial Natriuretic Factor; Biphenyl Compounds; Bradykinin; Cardiotonic Agents; Drug Combinations; Gene Expression Regulation; Humans; Mice; Myocardial Reperfusion Injury; Neprilysin; ST Elevation Myocardial Infarction; Substance P; Survival Analysis; Tetrazoles; Valsartan; Ventricular Remodeling | 2020 |
Mitochondrial angiotensin receptors and cardioprotective pathways.
Topics: Angiotensin II; Animals; Humans; Mitochondria, Heart; Myocardial Reperfusion Injury; Myocardium; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2019 |
[The bioactivity of angiotensin II and the effects of related Chinese Herbs].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Drugs, Chinese Herbal; Heart Failure; Humans; Hypertension; Myocardial Reperfusion Injury; Plants, Medicinal; Receptor, Angiotensin, Type 2 | 2003 |
Seminars in thrombosis, thrombolysis and vascular biology. 1. The vascular endothelium.
Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Coronary Artery Bypass; Endothelins; Endothelium, Vascular; Epoprostenol; Humans; Myocardial Reperfusion Injury; Nitric Oxide; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Vasomotor System | 1991 |
83 other study(ies) available for angiotensin ii and Injury, Myocardial Reperfusion
Article | Year |
---|---|
A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release.
Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; Cysteine; Disease Models, Animal; Gene Knock-In Techniques; Insulin Resistance; Membrane Proteins; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Myocardial Reperfusion Injury; Myocardium | 2019 |
Tackling PTEN induced putative kinase 1 in angiotensin II-induced myocardial injury.
Topics: Angiotensin II; Humans; Mitochondria; Myocardial Reperfusion Injury; Protein Kinases; PTEN Phosphohydrolase | 2021 |
IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C.
Topics: Angiotensin II; Animals; Apoptosis; Cytochromes c; Interleukin-22; Interleukins; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Myocardial Reperfusion Injury; Myocytes, Cardiac; Reactive Oxygen Species; Signal Transduction | 2021 |
Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
Topics: Angiotensin II; Animals; Benzophenanthridines; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; MAP Kinase Signaling System; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Protein Kinase C-delta; Protein Kinase C-epsilon; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley | 2017 |
Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Heart; Losartan; Male; Mitochondria; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction | 2018 |
Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion.
Topics: AMP-Activated Protein Kinases; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cardiomegaly; Hyperthyroidism; Imidazoles; Male; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thyroxine; Triiodothyronine; Ventricular Pressure | 2013 |
Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Perfusion; Rats, Sprague-Dawley; Recovery of Function; Ventricular Function, Left; Ventricular Pressure | 2014 |
Prevention of export of anoxia/reoxygenation injury from ischemic to nonischemic cardiomyocytes via inhibition of endocytosis.
Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Beclin-1; CD36 Antigens; Cells, Cultured; Endocytosis; Hypoxia; Mice; Models, Animal; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxygen; Reactive Oxygen Species; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2014 |
Effects of acute angiotensin II on ischemia reperfusion injury following myocardial infarction.
Topics: Angiotensin II; Animals; Animals, Newborn; Body Weight; Cell Survival; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Rats, Wistar; Ultrasonography; Ventricular Remodeling | 2015 |
Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Diet, High-Fat; Female; Fetal Development; Genetic Predisposition to Disease; Heart Diseases; Imidazoles; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sex Characteristics | 2015 |
Maternal hyperthyroidism increases the susceptibility of rat adult offspring to cardiovascular disorders.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Newborn; Disease Models, Animal; Disease Susceptibility; Female; Hypertension; Hyperthyroidism; Male; Myocardial Reperfusion Injury; Plethysmography; Pregnancy; Pregnancy Complications; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Thyroxine | 2015 |
Sildenafil Protects against Myocardial Ischemia-Reperfusion Injury Following Cardiac Arrest in a Porcine Model: Possible Role of the Renin-Angiotensin System.
Topics: Angiotensin II; Animals; Apoptosis; Cardiopulmonary Resuscitation; Cardiotonic Agents; Cyclic GMP; Disease Models, Animal; Gene Expression Regulation; Heart Arrest; Hemodynamics; Male; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Phosphodiesterase 5 Inhibitors; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sildenafil Citrate; Swine | 2015 |
Angiotensin IV protects cardiac reperfusion injury by inhibiting apoptosis and inflammation via AT4R in rats.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Apoptosis; Cardiotonic Agents; Creatine Kinase; Male; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Protein Processing, Post-Translational; Rats, Sprague-Dawley; Receptors, Angiotensin | 2016 |
Coronary arterial BK channel dysfunction exacerbates ischemia/reperfusion-induced myocardial injury in diabetic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Caveolae; Cells, Cultured; Coronary Vessels; Diabetic Cardiomyopathies; HEK293 Cells; Humans; Kv1.3 Potassium Channel; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Large-Conductance Calcium-Activated Potassium Channel beta Subunits; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Mutation; Myocardial Reperfusion Injury; Protein Transport; Receptor, Angiotensin, Type 1; Recombinant Proteins | 2016 |
Enalapril protects against myocardial ischemia/reperfusion injury in a swine model of cardiac arrest and resuscitation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Cardiopulmonary Resuscitation; Cardiotonic Agents; Disease Models, Animal; Enalapril; Gene Expression; Heart; Heart Arrest; Humans; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Myocardial Reperfusion Injury; Myocardium; Peptidyl-Dipeptidase A; Random Allocation; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Swine; Time Factors; Ventricular Fibrillation | 2016 |
The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Cardiac Pacing, Artificial; Heart; Hemodynamics; Irbesartan; Male; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles | 2016 |
Inhibition of Angiotensin-II Production Increases Susceptibility to Acute Ischemia/Reperfusion Arrhythmia.
Topics: Amides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Captopril; Creatine Kinase, MB Form; Fumarates; Heart; Heart Rate; Male; Myocardial Reperfusion Injury; Oxidative Stress; Rats | 2016 |
PICOT alleviates myocardial ischemia-reperfusion injury by reducing intracellular levels of reactive oxygen species.
Topics: Angiotensin II; Animals; Carrier Proteins; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hydrogen Peroxide; Intracellular Space; Iron; Male; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidants; Protein Disulfide Reductase (Glutathione); Reactive Oxygen Species | 2017 |
Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Chromatography, High Pressure Liquid; Chymases; Coronary Vessels; Creatine Kinase; Hemodynamics; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Oligopeptides; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Serine Proteinase Inhibitors; Tandem Mass Spectrometry; Time Factors; Troponin I; Vasoconstriction; Ventricular Function, Left | 2009 |
Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; NF-kappa B; Nuclear Proteins; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 2009 |
A new addition to the renin-angiotensin peptide family: proAngiotensin-12 (PA12).
Topics: Angiotensin II; Angiotensinogen; Animals; Biomarkers; Blood Pressure; Chymases; Coronary Vessels; Creatine Kinase; Hemodynamics; Humans; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Rats; Renin-Angiotensin System; Troponin I; Vasoconstriction; Ventricular Function, Left | 2009 |
Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation.
Topics: Angiotensin II; Animals; Cardiac Pacing, Artificial; Catecholamines; Disease Models, Animal; Electrocardiography; Heart Rate; Male; Mice; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Perfusion; Time Factors; Ventricular Fibrillation | 2009 |
Cardioprotection by CaMKII-deltaB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70.
Topics: Angiotensin II; Animals; Apoptosis; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; DNA-Binding Proteins; Gene Expression Regulation; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Hydrogen Peroxide; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidants; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factors | 2010 |
Adrenomedullin attenuates aortic cross-clamping-induced myocardial injury in rats.
Topics: Adrenomedullin; Angiotensin II; Animals; Aorta; Apoptosis; Biomarkers; Caspase 3; Catalase; Constriction; Endothelin-1; Immunohistochemistry; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Superoxide Dismutase; Troponin I; Tumor Necrosis Factor-alpha | 2011 |
Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Enalapril; Feasibility Studies; Male; Myocardial Reperfusion Injury; Myocardium; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Tissue Distribution; Valine; Valsartan | 2010 |
Gene expression, function and ischemia tolerance in male and female rat hearts after sub-toxic levels of angiotensin II.
Topics: Angiotensin II; Animals; Apoptosis; Collagen; Disease Models, Animal; Female; Fibrosis; Gene Expression Regulation; Infusion Pumps, Implantable; Infusions, Subcutaneous; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Inbred BN; Rats, Inbred F344; Recovery of Function; Sex Factors; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Brain; Captopril; Cytokines; Heart; Hydralazine; Hypertension; In Vitro Techniques; Insulin; Kidney; Leptin; Male; Myocardial Contraction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Perfusion; Proteinuria; Rats; Rats, Inbred SHR; Ventricular Function, Left | 2011 |
Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats.
Topics: Angiotensin II; Animals; Antioxidants; Cardiotonic Agents; China; Creatine Kinase; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelins; Ginsenosides; Heart Ventricles; L-Lactate Dehydrogenase; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Panax; Phytotherapy; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley; Single-Blind Method; Superoxide Dismutase | 2011 |
Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cells, Cultured; Dietary Fats; Disease Models, Animal; Genetic Predisposition to Disease; Glucose Tolerance Test; Glucose Transporter Type 4; Heredity; HSP72 Heat-Shock Proteins; Hyperthermia, Induced; Insulin Resistance; Male; Myocardial Reperfusion Injury; Myocardium; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Recovery of Function; Tetrazoles; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.
Topics: Angiotensin II; Animals; Guinea Pigs; Heart; Histamine Agonists; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nerve Endings; Neurons; Nitric Oxide; PC12 Cells; Protein Kinase C; Rats; Receptor, Angiotensin, Type 1; Receptors, Histamine H3; Sodium-Hydrogen Exchangers; Sympathetic Nervous System; Synaptosomes; Tetradecanoylphorbol Acetate | 2012 |
Preconditioning protects the heart in a prolonged uremic condition.
Topics: Angiotensin II; Animals; Biomarkers; Creatinine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Urea; Uremia; Uric Acid; Ventricular Function, Left | 2012 |
Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Coronary Circulation; Enzyme Activation; Heart; In Vitro Techniques; L-Lactate Dehydrogenase; Losartan; Male; Membrane Glycoproteins; Membrane Transport Proteins; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NADPH Dehydrogenase; NADPH Oxidase 2; NADPH Oxidases; Perfusion; Phosphoproteins; Rats; Rats, Wistar; RNA, Messenger; Vasoconstrictor Agents; Ventricular Function, Left | 2003 |
The role of endogenous angiotensin II in ischaemia, reperfusion and preconditioning of the isolated rat heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Female; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Losartan; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchangers | 2003 |
Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bleeding Time; Captopril; Disease Models, Animal; Endothelium, Vascular; Female; Hemodynamics; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Vasodilation; Ventricular Fibrillation | 2003 |
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
Topics: Angiotensin II; Animals; Blood Glucose; Cardiac Output; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Obesity; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2005 |
Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II.
Topics: Acetophenones; Angiotensin II; Animals; Cardiotonic Agents; Decanoic Acids; Enzyme Activation; Enzyme Inhibitors; Hydroxy Acids; Ischemic Preconditioning, Myocardial; Lipid Peroxidation; Mitochondria; Mitogen-Activated Protein Kinases; Myocardial Reperfusion Injury; Myocardium; NADPH Oxidases; Phagocytes; Rats; Reactive Oxygen Species; Superoxides | 2005 |
Cumulative effects of AT1 and AT2 receptor blockade on ischaemia-reperfusion recovery in rat hearts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Recovery of Function; Tetrazoles; Valine; Valsartan; Ventricular Function, Left | 2005 |
[Relationship between apoptosis and alteration of the energetic metabolism pathways of hypertrophic cardiomyocytes induced by hypoxia-reoxygenation].
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cell Enlargement; Cell Hypoxia; Energy Metabolism; Myocardial Reperfusion Injury; Myocytes, Cardiac; Norepinephrine; Oxygen; Rats | 2005 |
Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Northern; Blotting, Western; Cell Hypoxia; Cells, Cultured; Collagen Type I; Collagen Type III; Electrophoretic Mobility Shift Assay; Fibroblasts; Gene Expression; Ligands; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle Cells; Myocardial Reperfusion Injury; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Oxygen; Pioglitazone; PPAR gamma; Prostaglandin D2; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1 | 2006 |
Angiotensin preconditioning of the heart: evidence for redox signaling.
Topics: Acetophenones; Acetylcysteine; Angiotensin II; Animals; Antioxidants; Apoptosis; Gene Expression; Heart; Heart Rate; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Membrane Glycoproteins; Membrane Transport Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Oxidation-Reduction; Perfusion; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling | 2006 |
Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling.
Topics: Angiotensin II; Animals; Apoptosis; Ischemic Preconditioning, Myocardial; Male; MAP Kinase Signaling System; Multienzyme Complexes; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Perfusion; Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2006 |
Preconditioning by angiotensin II: a tale of more than two kinases.
Topics: Angiotensin II; Animals; Apoptosis; Ischemic Preconditioning, Myocardial; Male; MAP Kinase Signaling System; Multienzyme Complexes; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Perfusion; Protein Kinases; Rats; Reactive Oxygen Species | 2006 |
Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection.
Topics: Androstadienes; Angiotensin II; Animals; Blotting, Western; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Inbred C57BL; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oncogene Protein v-akt; Perfusion; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Time Factors; Wortmannin | 2007 |
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Arginine; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Heart Rate; Male; Myocardial Reperfusion Injury; Nitrates; Nitrites; Perfusion; Rats; Rats, Wistar; RNA, Messenger; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Dysfunction | 2007 |
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles | 1995 |
Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system.
Topics: Angiotensin II; Animals; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Renin; Renin-Angiotensin System | 1995 |
Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Creatine Kinase; Heart; Heart Rate; Heart Ventricles; Indans; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Tetrazoles; Ventricular Pressure | 1994 |
The deleterious effects of exogenous angiotensin I and angiotensin II on myocardial ischemia-reperfusion injury.
Topics: Angiotensin I; Angiotensin II; Animals; Coronary Circulation; Creatine Kinase; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Inbred WKY; Renin-Angiotensin System | 1994 |
Effect of captopril cardioplegia on renin-angiotensin system, prostaglandins, free radicals and electrolytes in the isolated hypothermic ischemic and reperfusion rabbit hearts.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Captopril; Cardioplegic Solutions; Electrolytes; Free Radical Scavengers; In Vitro Techniques; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Rabbits; Renin-Angiotensin System; Thromboxane B2 | 1993 |
Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Coronary Circulation; Disease Models, Animal; Dogs; Enalaprilat; Female; Furosemide; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Renin-Angiotensin System; Tetrazoles | 1993 |
Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and in ischaemia and reperfusion.
Topics: Angiotensin II; Animals; Coronary Vessels; Endothelins; Endothelium; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Thrombin; Vasoconstrictor Agents | 1995 |
The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Female; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium | 1996 |
Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Bradykinin Receptor Antagonists; Endothelin Receptor Antagonists; Endothelins; Female; Heart; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1996 |
Hyperbaric oxygen worsens myocardial low flow ischemia-reperfusion injury in isolated rat heart.
Topics: Acetylcysteine; Angiotensin II; Animals; Coronary Circulation; Free Radical Scavengers; Heart; Hyperbaric Oxygenation; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Polydeoxyribonucleotides; Rats; Rats, Sprague-Dawley; Time Factors; Vasoconstrictor Agents; Ventricular Pressure | 1997 |
Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Heart Rate; Hemodynamics; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Inbred SHR | 1997 |
Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Antibodies; Coronary Circulation; Endothelium, Vascular; Growth Hormone; Growth Hormone-Releasing Hormone; Growth Substances; Immunization, Passive; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oligopeptides; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Ventricular Pressure | 1997 |
Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period.
Topics: Angiotensin II; Animals; Animals, Newborn; Body Weight; Endothelin-1; Female; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Factors; Sex Factors; Tobacco Smoke Pollution | 1997 |
Cardiac effects of angiotensin I and angiotensin II: dose-response studies in the isolated perfused rat heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dose-Response Relationship, Drug; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Sprague-Dawley | 1998 |
Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.
Topics: 6-Ketoprostaglandin F1 alpha; Aging; Angiotensin II; Animals; Growth Hormone; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Oligopeptides; Protective Agents; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 1998 |
Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; In Vitro Techniques; Losartan; Male; Myocardial Reperfusion Injury; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger | 1998 |
[Effect of phenylephrine, endothelin and angiotensin II on reperfusion arrhythmias. A role for Na+/H+ exchanger activation via protein kinase C].
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Endothelins; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Phenylephrine; Protein Kinase C; Rats; Rats, Wistar; Sarcolemma; Sodium-Hydrogen Exchangers; Ventricular Fibrillation | 1998 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post-ischaemic damage in rats.
Topics: Aging; Angiotensin II; Animals; Antioxidants; Ascorbic Acid; Biflavonoids; Blood Glucose; Body Weight; Catechin; Cholesterol; Chromans; Creatine Kinase; Dietary Supplements; Epoprostenol; Heart; Male; Myocardial Reperfusion Injury; Myocardium; Proanthocyanidins; Rats; Rats, Wistar; Triglycerides; Uric Acid; Vitamin E | 1999 |
Role of angiotensin in cardioprotective effect of ischemic preconditioning.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Coronary Circulation; Creatine Kinase; Female; Heart Rate; Imidazoles; In Vitro Techniques; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Wistar; Tetrazoles | 1999 |
Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
Topics: Adenosine Triphosphate; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Circulation; In Vitro Techniques; Isoquinolines; Losartan; Male; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrahydroisoquinolines; Ventricular Function, Left; Ventricular Pressure | 1999 |
Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation.
Topics: Analysis of Variance; Angiotensin II; Antihypertensive Agents; Apoptosis; Cells, Cultured; Coronary Vessels; Endothelium, Vascular; fas Receptor; Humans; Losartan; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-bcl-2; Receptors, Angiotensin; RNA, Messenger | 1999 |
Growth hormone-independent cardioprotective effects of hexarelin in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Creatine Kinase; Growth Hormone; Heart; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oligopeptides; Rats; Rats, Sprague-Dawley | 1999 |
Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Creatine Kinase; Dose-Response Relationship, Drug; Heart; Hemodynamics; In Vitro Techniques; Losartan; Male; Myocardial Reperfusion Injury; Norepinephrine; Perfusion; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Panax ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: evidence for an antioxidant intervention.
Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Endothelium, Vascular; Free Radical Scavengers; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Oxygen; Panax; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Pressure | 1999 |
The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Bradykinin; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Female; Kidney; Lung; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neprilysin; Peptidyl-Dipeptidase A; Phenylalanine | 2000 |
Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Captopril; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Treatment Outcome; Ventricular Fibrillation | 2000 |
Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Aspirin; Creatine Kinase; Dose-Response Relationship, Drug; Electrocardiography; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Peroxidase; Rabbits; Vasoconstrictor Agents; Ventricular Function, Left | 2000 |
Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular Agents; Colchicine; Creatine Kinase; Female; Heart; In Vitro Techniques; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Polymyxins; Prazosin; Rats; Rats, Wistar; Reserpine; Tyramine | 2000 |
Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Coronary Circulation; Dogs; Heart; Hemodynamics; Injections, Intravenous; Irbesartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Tetrazoles | 2000 |
Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia.
Topics: Angiotensin II; Animals; Animals, Newborn; Captopril; Cells, Cultured; Losartan; Male; Myocardial Reperfusion Injury; Paracrine Communication; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2001 |
Effect of ethylisopropyl amiloride, a Na+ - H+ exchange inhibitor, on cardioprotective effect of ischaemic and angiotensin preconditioning.
Topics: Amiloride; Angiotensin II; Animals; Cardiovascular Agents; Creatine Kinase; Female; Hemodynamics; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Sodium-Hydrogen Exchangers | 2000 |
[The protective effect of captopril during myocardial ischemia and reperfusion and its mechanism].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dogs; Endothelin-1; Female; Heart Function Tests; Male; Myocardial Reperfusion Injury; Myocardium; Random Allocation | 1998 |
Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Captopril; Genetic Therapy; Male; Myocardial Reperfusion Injury; Myocardium; Oligonucleotides, Antisense; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2001 |
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Heart Ventricles; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Rats; Rats, Wistar | 2001 |
Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, Animal; Endothelial Growth Factors; Endothelium, Vascular; Female; Losartan; Lymphokines; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilation | 2001 |
The pathophysiological basis of arrhythmogenesis in myocardial ischemia and reperfusion: possible target for intervention.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Catecholamines; Cyclic AMP; Free Radicals; Humans; Myocardial Reperfusion Injury; Potassium; Rabbits | 1991 |
Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Female; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains | 1987 |
Atrial natriuretic factor protects the isolated working ischaemic rat heart against the action of angiotensin II.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Coronary Circulation; Coronary Disease; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains; Ventricular Fibrillation | 1988 |